Xiaowei Chang
Director/Board Member at AMBRX INC
Xiaowei Chang active positions
| Companies | Position | Start | End |
|---|---|---|---|
| AMBRX INC | Director/Board Member | 2015-05-31 | - |
Hopu Investments Co. Ltd.
 Hopu Investments Co. Ltd. Financial ConglomeratesFinance Hopu Investments Co. Ltd. functions as an investment holding Caymanian company. | Corporate Officer/Principal | 2013-12-31 | - |
Career history of Xiaowei Chang
Former positions of Xiaowei Chang
| Companies | Position | Start | End |
|---|---|---|---|
Ambrx Biopharma, Inc.
 Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Director/Board Member | 2015-05-31 | 2023-10-05 |
| Independent Dir/Board Member | 2015-05-31 | 2023-10-05 | |
| China International Capital Corp. Ltd. (Private Equity) | Corporate Officer/Principal | 2010-12-31 | 2013-12-31 |
Training of Xiaowei Chang
| Tsinghua University | Graduate Degree |
Statistics
International
| United States | 3 |
| China | 3 |
| Cayman Islands | 2 |
Operational
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
| Independent Dir/Board Member | 1 |
Sectoral
| Health Technology | 3 |
| Finance | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 4 |
|---|---|
Ambrx, Inc.
 Ambrx, Inc. Pharmaceuticals: MajorHealth Technology Ambrx, Inc. engages in discovering and developing of protein therapeutics. It offers non-native amino acids through expanded genetic code to both generate novel bio-therapeutics. The company was founded by Richard DiMarchi, Peter G. Schultz, and Troy E. Wilson on April 15, 2003 and is headquartered in La Jolla, CA. | Health Technology |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Health Technology |
| China International Capital Corp. Ltd. (Private Equity) | Finance |
Hopu Investments Co. Ltd.
Hopu Investments Co. Ltd. Financial ConglomeratesFinance Hopu Investments Co. Ltd. functions as an investment holding Caymanian company. | Finance |
- Stock Market
- Insiders
- Xiaowei Chang
- Experience
